Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Geyer

Showing results (21-30 of 118) with videos related to

Pageof 12
Sort By:
Blood|May 1, 2020
How I treat pain in hematologic malignancies safely with opioid therapyHolly L Geyer, Halena Gazelka, Ruben Mesa
Hematology (Amsterdam, Netherlands)|April 18, 2012
JAK2 inhibitors and their impact in myeloproliferative neoplasmsHolly L Geyer, Raoul Tibes, Ruben A Mesa
Neurology|April 13, 2005
Methyl bromide intoxication causes reversible symmetric brainstem and cerebellar MRI lesionsHoward L Geyer, Herbert H Schaumburg, Steven Herskovitz
JRSM Open|July 28, 2017
A case of hypercalcaemia in an immunocompetent patient with <i>Mycobacterium avium</i> intracellulareChristine E Parsons, Sujata Singh, Holly L Geyer
Das Deutsche Gesundheitswesen|October 21, 1971
[Polycythemia vera in young adults]L Geyer, D Nelius, J Schulz, et al.
Neurology|April 3, 2013
Teaching video neuroimages: orthostatic tremor: the helicopter signVincent S DeOrchis, Howard L Geyer, Steven Herskovitz
International Journal of Pediatric Otorhinolaryngology|February 18, 2019
Pediatric tracheostomy first tube change: When is it safe?R Woods, L Geyer, R Mehanna, et al.
American Journal of Law & Medicine|November 24, 2015
The Food Safety Modernization Act: Implications for U.S. Small Scale FarmsKathryn A Boys, Michael Ollinger, Leon L Geyer
Current Hematologic Malignancy Reports|September 29, 2014
Quality of life in MPN comes of age as a therapeutic targetRobyn M Scherber, Holly L Geyer, Ruben A Mesa
Leukemia & Lymphoma|February 4, 2015
Reducing symptom burden in patients with myeloproliferative neoplasms in the era of Janus kinase inhibitorsRuben A Mesa, Robyn M Scherber, Holly L Geyer
Pageof 12

Showing results (21-30 of 118) with videos related to

Sort By:
Pageof 12
Blood|May 1, 2020
How I treat pain in hematologic malignancies safely with opioid therapyHolly L Geyer, Halena Gazelka, Ruben Mesa
Hematology (Amsterdam, Netherlands)|April 18, 2012
JAK2 inhibitors and their impact in myeloproliferative neoplasmsHolly L Geyer, Raoul Tibes, Ruben A Mesa
Neurology|April 13, 2005
Methyl bromide intoxication causes reversible symmetric brainstem and cerebellar MRI lesionsHoward L Geyer, Herbert H Schaumburg, Steven Herskovitz
JRSM Open|July 28, 2017
A case of hypercalcaemia in an immunocompetent patient with <i>Mycobacterium avium</i> intracellulareChristine E Parsons, Sujata Singh, Holly L Geyer
Das Deutsche Gesundheitswesen|October 21, 1971
[Polycythemia vera in young adults]L Geyer, D Nelius, J Schulz, et al.
Neurology|April 3, 2013
Teaching video neuroimages: orthostatic tremor: the helicopter signVincent S DeOrchis, Howard L Geyer, Steven Herskovitz
International Journal of Pediatric Otorhinolaryngology|February 18, 2019
Pediatric tracheostomy first tube change: When is it safe?R Woods, L Geyer, R Mehanna, et al.
American Journal of Law & Medicine|November 24, 2015
The Food Safety Modernization Act: Implications for U.S. Small Scale FarmsKathryn A Boys, Michael Ollinger, Leon L Geyer
Current Hematologic Malignancy Reports|September 29, 2014
Quality of life in MPN comes of age as a therapeutic targetRobyn M Scherber, Holly L Geyer, Ruben A Mesa
Leukemia & Lymphoma|February 4, 2015
Reducing symptom burden in patients with myeloproliferative neoplasms in the era of Janus kinase inhibitorsRuben A Mesa, Robyn M Scherber, Holly L Geyer
Pageof 12